Randomised open label clinical trial of the immune response to hepatitis B vaccination [hepatitis B vaccine recombinant] in HIV-infected persons.
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2011
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 18 Feb 2011 Primary endpoint 'Antibody-levels' has not been met
- 25 Jan 2011 Results published in the Journal of Infectious Diseases.
- 01 Jun 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.